Tiziana Life Sciences CEO Buys Shares

Ticker: TLSA · Form: 6-K · Filed: Sep 9, 2025 · CIK: 1723069

Sentiment: bullish

Topics: insider-buy, ceo-purchase, biotech

TL;DR

CEO Elrifi just bought 193,848 Tiziana shares at $1.65 - bullish signal?

AI Summary

On September 9, 2025, Tiziana Life Sciences LTD announced that its CEO, Ivor Elrifi, purchased 193,848 shares of the company's common stock in the open market. The shares were acquired at a price of $1.65 per share.

Why It Matters

Insider buying can signal confidence from leadership in the company's future prospects.

Risk Assessment

Risk Level: medium — Insider buying is generally positive, but the overall financial health and market performance of Tiziana Life Sciences will determine the true risk.

Key Numbers

Key Players & Entities

FAQ

What is the total dollar amount of the CEO's stock purchase?

The CEO, Ivor Elrifi, purchased 193,848 shares at $1.65 per share, totaling approximately $319,849.20.

When did this stock purchase occur?

The announcement of the purchase was made on September 9, 2025, and the purchase was made in the open market.

What is the filing type and its purpose?

This is a Form 6-K, which is a Report of Foreign Private Issuer, used to announce significant events or information to the SEC.

What is Tiziana Life Sciences' primary business?

Tiziana Life Sciences is in the Pharmaceutical Preparations industry (SIC code 2834).

Where is Tiziana Life Sciences headquartered?

Tiziana Life Sciences LTD is headquartered in London, England.

Filing Stats: 312 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2025-09-09 08:30:02

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TIZIANA LIFE SCIENCES LTD Date: September 9, 2025 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 2 EXHIBIT INDEX Exhibit No. Description 99.1 Tiziana Life Sciences LTD Press Release, dated September 9, 2025 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing